سيبروفلوكساسين تيڤع ٢٥٠ ملغ أقراص

Country: Iżrael

Lingwa: Għarbi

Sors: Ministry of Health

Ingredjent attiv:

CIPROFLOXACIN AS HYDROCHLORIDE 250 MG

Disponibbli minn:

TEVA PHARMACEUTICAL INDUST.LTD

Kodiċi ATC:

S03AA07

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupp terapewtiku:

CIPROFLOXACIN

Indikazzjonijiet terapewtiċi:

Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. Treatment of acute pulmonary exacerbation of cystic fibrosis associated with P. aeruginosa infections in pediatric patients aged 5-17 years.

Data ta 'l-awtorizzazzjoni:

2012-03-01